newsfilter
← Latest News
GlobeNewswire·

Ikena Oncology to Participate in the William Blair Biotech Focus Conference 2022

BOSTON, July 06, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (NASDAQ:IKNA, "Ikena"))), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that Mark Manfredi, Ph.D., Chief Executive Officer of Ikena